Skip to main content
. Author manuscript; available in PMC: 2016 May 27.
Published in final edited form as: J Oncol Pharm Pract. 2013 Oct 11;20(5):332–340. doi: 10.1177/1078155213507010

Figure 1.

Figure 1

Bevacizumab use by calendar year (all eligible versus initially diagnosed stage IV colorectal cancer patients; number of all patients in parentheses).